Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab

Introduction: Belimumab is a monoclonal antibody against soluble BLyS used for treatment of refractory Systemic Lupus Erythematosus (SLE). Although B cells are the main target of this therapy, a BLyS-dependent T cell activation pathway has also been demonstrated. The aim of the study is to analyze B...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Pharmacol
Autors principals: Regola, Francesca, Piantoni, Silvia, Lowin, Torsten, Archetti, Silvia, Reggia, Rossella, Kumar, Rajesh, Franceschini, Franco, Airò, Paolo, Tincani, Angela, Andreoli, Laura, Pongratz, Georg
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2019
Matèries:
Pharmacology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494924/
https://ncbi.nlm.nih.gov/pubmed/31105569
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00433
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars